(Q35755924)

English

Multiscale assessment of treatment efficacy in adults with ADHD: a randomized placebo-controlled, multi-centre study with extended-release methylphenidate

scientific article published on 14 December 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Multiscale assessment of treatment efficacy in adults with ADHD: a randomized placebo-controlled, multi-centre study with extended-release methylphenidate (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

0 references

4

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

5

object named as

Barbara Alm

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Alexandra Philipsen

6

object named as

Alexandra Philipsen

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

author name string

Wolfgang Retz

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Michael Rösler

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Claudia Ose

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Roland Fischer

7

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Richard Ammer

8

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Study Group

9

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

publication date

14 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

48-59

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Attention deficit hyperactivity disorder in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279134

2 October 2017

Psychopathological rating scales as efficacy parameters in adult ADHD treatment investigations - benchmarking instruments for international multicentre trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279134

2 October 2017

A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279134

2 October 2017

Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279134

2 October 2017

Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279134

2 October 2017

Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279134

2 October 2017

Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279134

2 October 2017

The consequences of attention-deficit/hyperactivity disorder in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279134

2 October 2017

Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279134

2 October 2017

Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279134

2 October 2017

Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279134

2 October 2017

Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279134

2 October 2017

Innovations in attention-deficit/hyperactivity disorder pharmacotherapy: long-acting stimulant and nonstimulant treatments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279134

2 October 2017

Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279134

12 July 2018

A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.540257

21 January 2018

Self concept, action control and ADHD symptoms under methylphenidate treatment in adults with ADHD.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.540257

21 January 2018

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.540257

21 January 2018

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.540257

21 January 2018

Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.540257

21 January 2018

Emotional dysregulation in adult ADHD and response to atomoxetine.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.540257

21 January 2018

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.540257

21 January 2018

Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.540257

21 January 2018

Methylphenidate transdermal system in adult ADHD and impact on emotional and oppositional symptoms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279134

25 September 2018

Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279134

25 September 2018

ADHD in adulthood--guidelines based on expert consensus with DGPPN support

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3279134

25 September 2018

Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/21155632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Wender Utah rating scale. The short-version for the assessment of the attention-deficit hyperactivity disorder in adults]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21155632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Reliability and validity of the Wender-Utah-Rating-Scale short form. Retrospective assessment of symptoms for attention deficit/hyperactivity disorder]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21155632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Tools for the diagnosis of attention-deficit/hyperactivity disorder in adults. Self-rating behaviour questionnaire and diagnostic checklist]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21155632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/21155632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Attention deficit hyperactivity disorder in adults. Benchmarking diagnosis using the Wender-Reimherr adult rating scale]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21155632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A one year trial of methylphenidate in the treatment of ADHD

1 reference

https://pubmed.ncbi.nlm.nih.gov/21155632

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3109/15622975.2010.540257

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35755924&oldid=1746213853"